Abstract
Staphylococcus aureus, a Gram-positive bacterium, can cause a range of illnesses from minor skin infections to life-threatening diseases, such as bacteraemia, endocarditis, meningitis, osteomyelitis, pneumonia, toxic shock syndrome and sepsis. Due to the emergence of antibiotic resistance strains, there is a need to develop of new class of antibiotics or drug for this pathogen. The phosphotransacetylase enzyme plays an important role in the acetate metabolism and found to be essential for the survival of the S. aureus. This enzyme was evaluated as a putative drug target for S. aureus by in silico analysis. The 3D structure of the phosphotransacetylase from S. aureus was modelled, using the 1TD9 chain ‘A’ from Bacillus subtilis as a template at the resolution of 2.75 Å. The generated model has been validated by PROCHECK, WHAT IF and SuperPose. The docking was performed by the Molegro virtual docker using the ZINC database generated ligand library. The ligand library was generated within the limitation of the Lipinski rule of five. Based on the dock-score, five molecules have been subjected to ADME/TOX analysis and subjected for pharmacophore model generation. The zinc IDs of the potential inhibitors are ZINC08442078, ZINC8442200, ZINC 8442087 and ZINC 8442184 and found to be pharmacologically active antagonist of phosphotransacetylase. The molecules were evaluated as no-carcinogenic and persistent molecule by START programme.
Similar content being viewed by others
References
Carleton, H. A., Diep, B. A., Charlebois, E. D., Sensabaugh, G. F., & Perdreau-Remington, F. (2004). Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases, 190, 1730–1738.
Diekema, D. J., Pfaller, M. A., & Schmitz, F. J. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial usceptibility of isolates collected in the SENTRY Antimicrobial Surveillance Program. Clinical Infectious Diseases, 32, S114–S132.
Freeman-cook, L., & Freeman-cook, K. (2006). Staphylococcus aureus infections (deadly diseases and epidemics). Philadelphia, Chelsea House Publications.
King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006). Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine, 144, 309–317.
Morya, V. K., Dewaker, V., Mecarty, S. D., & Singh, R. (2010). In silico analysis metabolic pathways for identification of putative drug targets for Staphylococcus aureus. Journal of Computer Science & Systems Biology, 3(3), 062–069.
Ross, R. A., & Onderdonk, A. B. (2000). Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infection and Immunity, 68(9), 5205–5209.
Yarwood, J. M., & Schlievert, P. M. (2003). Quorum sensing in Staphylococcus infections. The Journal of Clinical Investigation, 112(11), 1620–1625.
Bien, J., Sokolova, O., & Bozko, P. (2011). Characterization of virulence factors of Staphylococcus aureus: novel function of known virulence factors that are implicated in activation of airway epithelial proinflammatory response. Journal of Pathogens, 2011(601905), 13. doi:10.4061/2011/601905.
Deurenberg, R. H., & Stobberingh, E. E. (2008). The evolution of Staphylococcus aureus. Infection, Genetics and Evolution, 8(6), 747–763.
Ellis, M. W., Griffith, M. E., Jorgensen, J. H., Hospenthal, D. R., Mende, K., & Patterson, J. E. (2009). Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureusstrains colonizing and infecting soldiers. Journal of Clinical Microbiology, 47(4), 940–945.
Ferry, T., Perpoint, T., Vandenesch, F., & Etienne, J. (2005). Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes. Current Infectious Disease Reports, 7, 420–428.
Hogevik, H., Söderquist, B., Tung, H. S., Olaison, L., Westberg, A., Rydén, C., Tarkowski, A., & Andersson, R. (1998). Virulence factors of Staphylococcus aureus strains causing infective endocarditis—a comparison with strains from skin infections. APMIS, 106(9), 901–908.
Spanu, V., Spanu, C., Virdis, S., Cossu, F., Scarano, C., & De Santis, E. P. (2012). Virulence factors and genetic variability of Staphylococcus aureus strains isolated from raw sheep’s milk cheese. International Journal of Food Microbiology, 153(1–2), 53–57.
Lowy, F. D. (1998). Staphylococcus aureusinfections. The New England Journal of Medicine, 339, 520–532.
Sarkar, M., Maganti, L., Ghoshal, N., & Dutta, C. (2012). In silico quest for putative drug targets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway. Journal of Molecular Modelling, 18(5), 1855–1866.
Perumal, D., Lim, C. S., Sakharkar, K. R., & Sakharkar, M. K. (2007). Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification. Silico Biology, 7(4–5), 453–465.
Butt, A. M., Tahir, S., Nasrullah, I., Idrees, M., Lu, J., & Tong, Y. (2012). Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets. Infection, Genetics and Evolution, 12(1), 53–62.
Morya, V. K., Kumari, S., & Kim, E. (2011). Imperative pathway analysis to identify the potential drug target for Aspergillus infection. International Journal of Latest Trends in Computing, 2(1), 178–182.
Morya, V. K., Kumari, S., & Kim, E. K. (2012). Virtual screening and evaluation of ketol-acid reducto-isomerase (KARI) as a putative drug target for aspergillosis. Clinical Proteomics, 9(1), 1.
Dutta, A., Singh, S. K., Ghosh, P., Mukherjee, R., Mitter, S., & Bandyopadhyay, D. (2006). In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. Silico Biology, 6(1–2), 43–47.
Singh, S., Joshi, P., & Chopade, B. A. (2011). Pathway analysis of Acinetobacter baylyi: a combined bioinformatic and genomics approach. Chemical Biology & Drug Design, 78(5), 893–905. doi:10.1111/j.1747-0285.2011.01191.x.
Bologna, F. P., Campos-Bermudez, V. A., Saavedra, D. D., Andreo, C. S., & Drincovich, M. F. (2010). Characterization of Escherichia coli EutD: a phosphotransacetylase of the ethanolamine operon. Journal of Microbiology, 48(5), 629–636.
Campos-Bermudez, V. A., Bologna, F. P., Andreo, C. S., & Drincovich, M. F. (2010). Functional dissection of Escherichia coli phosphotransacetylase structural domains and analysis of key compounds involved in activity regulation. FEBS Journal, 277(8), 1957–1966.
Dimou, M., Venieraki, A., Liakopoulos, G., & Katinakis, P. (2011). Cloning, characterization and transcriptional analysis of two phosphate acetyltransferase isoforms from Azotobacter vinelandii. Molecular Biology Reports, 38(6), 3653–3663.
Xu, Q. S., Jancarik, J., Lou, Y., Kuznetsova, K., Yakunin, A. F., Yokota, H., Adams, P., Kim, R., & Kim, S. H. (2005). Crystal structures of a phosphotransacetylase from Bacillus subtilis and its complex with acetyl phosphate. Journal of Structural and Functional Genomics, 6(4), 269–279.
Iyer, P. P., Lawrence, S. H., Luther, K. B., Rajashankar, K. R., Yennawar, H. P., Ferry, J. G., & Schindelin, H. (2004). Crystal structure of phosphotransacetylase from the methanogenic archaeon Methanosarcina thermophile. Structure, 12(4), 559–567.
Rasche, M. E., Smith, K. S., & Ferry, G. J. (1997). Identification of cysteine and arginine residues essential for the phosphotransacetylase from Methanosarcina thermophile. Journal of Bacteriology, 179(24), 7712–7717.
Gill, S. C., & Von Hippel, P. H. (1989). Extinction coefficient. Analytical Biochemistry, 182, 319–328.
Guruprasad, K., Reddy, B. V. P., & Pandit, M. W. (1990). Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protection Engineering, 4, 155–164.
Ikai, A. J. (1980). Thermo stability and aliphatic index of globular proteins. Journal of Biochemistry, 88, 1895–1898.
Kyte, J., & Doolottle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology, 157, 105–132.
Gasteiger, E. (2005). Protein identification and analysis tools on the ExPASy Server. In: J. M. Walker (Ed.), The proteomics protocols handbook (pp. 571–607). Totowa: Humana.
Geourjon, C., & Deléage, G. (1995). SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Computer Applications in the Biosciences, 11, 681–684.
Lu, Z., Szafron, D., Greiner, R., Lu, P., Wishart, D. S., Poulin, B., Anvik, J., Macdonell, C., & Eisner, R. (2004). Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics, 20(4), 547–556.
Falquet, L., Pagni, M., Bucher, P., Hulo, N., Sigrist, C. J., Hofmann, K., & Bairoch, A. (2002). The PROSITE database, its status in 2002. Nucleic Acids Research, 30(1), 235–238.
Lambert, C., Léonard, N., De Bolle, X., & Depiereux, E. (2002). ESyPred3D: prediction of proteins 3D structures. Bioinformatics, 18(9), 1250–1256.
Heinig, M., & Frishman, D. (2004). STRIDE: a web server for secondary structure assignment from known atomic coordinates of protein. Nucleic Acids Research, 32, W500–W502.
Krieger, E., Joo, K., Lee, J., Lee, J., Raman, S., Thompson, J., Tyka, M., Baker, D., & Karplus, K. (2009). Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins, 77(Suppl 9), 114–122.
Maiti, R., Gary, H., Domselaar, V., Zhang, H., & Wishart, D. S. (2004). SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Research, 32, W590–W594.
Laskoswki, R. A., MacArthur, M. W., Moss, D. S., & Thorton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26, 283–291.
Porter, C. T., Bartlett, G. J., & Thornton, J. M. (2004). The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Research, 32, D129–D133.
Irwin, J. J., & Shoichet, B. K. (2005). ZINC—a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182.
Thomsen, R., & Christensen, M. H. (2006). MolDock: a new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry, 49(11), 3315–3321.
Wolber, G., & Langer, T. (2005). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160–169.
Wolber, G., Seidel, T., Bendix, F., & Langer, T. (2008). Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discovery Today, 13(1–2), 23–29.
Lawrence, S. H., Luther, K. B., Schindelin, H., & Ferry, J. G. (2006). Structural and functional studies suggest a catalytic mechanism for the phosphotransacetylase from Methanosarcina thermophila. Journal of Bacteriology, 188(3), 1143–1154.
Lee, M. R., Tsai, J., Baker, D., & Kollman, P. A. (2001). Molecular dynamics in the endgame of protein structure prediction. Journal of Molecular Biology, 313, 417–430.
Engh, R. A., & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallographica, A47, 392–400.
Vianna, C. P., & de Azevedo, W. F., Jr. (2012). Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations. Journal of Molecular Modelling, 18(2), 755–764.
Wermuth, C., & Langer, T. (1998). In H. Kubinyi (Ed.), Pharmacophore Identification (pp. 117–136). Leiden: Escom.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26.
Morya, V. K., Yadav, S., Kim, E. K., & Yadav, D. (2012). In silico characterization of alkaline proteases from different species of Aspergillus. Applied Biochemistry and Biotechnology, 166(1), 243–257.
Moraes, F. P., & de Azevedo, W. F., Jr. (2012). Targeting imidazoline site on monoamine oxidase B through molecular docking simulations. Journal of Molecular Modelling, 18, 3877–3886. doi:10.1007/s00894-012-1390-7.
Heberlé, G., & De Azevedo, W. F., Jr. (2011). Bio-inspired algorithms applied to molecular docking simulations. Current Medicinal Chemistry, 18(9), 1339–1352.
Dias, R., & de Azevedo, W. F., Jr. (2008). Molecular docking algorithms. Current Drug Targets, 9(12), 1040–1047.
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule–ligand interactions. Journal of Molecular Biology, 161(2), 269–288.
DesJarlais, R. L., Seibel, G. L., Kuntz, I. D., Furth, P. S., Alvarez, J. C., Ortiz de Montellano, P. R., De Camp, D. L., Babé, L. M., & Craik, C. S. (1990). Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proceedings of the National Academy of Sciences of the United States of America, 87(17), 6644–6648.
Acknowledgments
This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant no. A103017). The work was also supported in part by Inha University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morya, V.K., Dewaker, V. & Kim, EK. In Silico Study and Validation of Phosphotransacetylase (PTA) as a Putative Drug Target for Staphylococcus aureus by Homology-Based Modelling and Virtual Screening. Appl Biochem Biotechnol 168, 1792–1805 (2012). https://doi.org/10.1007/s12010-012-9897-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9897-z